Total Payments
$10,363
2024 Payments
$1,755
Companies
39
Transactions
601
Medicare Patients
1,237
Medicare Billing
$71,016
Payment Breakdown by Category
Food & Beverage$10,357 (99.9%)
Education$6.35 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,357 | 600 | 99.9% |
| Education | $6.35 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,330 | 83 | $0 (2024) |
| Lilly USA, LLC | $1,277 | 74 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,163 | 64 | $0 (2024) |
| ABBVIE INC. | $1,130 | 67 | $0 (2024) |
| GlaxoSmithKline, LLC. | $980.53 | 61 | $0 (2024) |
| Astellas Pharma US Inc | $613.14 | 31 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $597.39 | 33 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $312.15 | 21 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $304.00 | 16 | $0 (2024) |
| Amarin Pharma Inc. | $293.30 | 17 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,755 | 88 | Lilly USA, LLC ($273.58) |
| 2023 | $2,080 | 112 | Novo Nordisk Inc ($428.42) |
| 2022 | $1,743 | 94 | ABBVIE INC. ($273.13) |
| 2021 | $1,957 | 118 | AbbVie Inc. ($379.51) |
| 2020 | $989.10 | 62 | AstraZeneca Pharmaceuticals LP ($213.77) |
| 2019 | $1,244 | 85 | GlaxoSmithKline, LLC. ($284.69) |
| 2018 | $347.97 | 24 | GlaxoSmithKline, LLC. ($73.35) |
| 2017 | $247.47 | 18 | Shire North American Group Inc ($50.38) |
All Payment Transactions
601 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Cardio-renal | ||||||
| 11/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Endocrinology | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.62 | General |
| 10/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Biological | ||||||
| 10/17/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: Endocrinology | ||||||
| 10/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Biological | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Gastroenterology | ||||||
| 08/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $32.53 | General |
| Category: Oncology | ||||||
| 08/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.12 | General |
| 08/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Gastroenterology | ||||||
| 07/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Cardio-renal | ||||||
| 07/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: PSYCHIATRY | ||||||
| 07/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Biological | ||||||
| 07/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.09 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.22 | General |
| 07/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 443 | 528 | $73,946 | $25,932 |
| 2022 | 8 | 356 | 402 | $53,670 | $19,958 |
| 2021 | 6 | 224 | 270 | $37,395 | $14,434 |
| 2020 | 7 | 214 | 263 | $31,675 | $10,693 |
Total Patients
1,237
Total Services
1,463
Medicare Billing
$71,016
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 161 | $37,835 | $8,972 | 23.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 16 | 16 | $6,160 | $4,526 | 73.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 67 | 67 | $11,390 | $4,467 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 37 | $5,750 | $1,941 | 33.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 24 | 24 | $2,040 | $1,723 | 84.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 22 | 25 | $3,875 | $1,424 | 36.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 98 | 124 | $2,480 | $1,042 | 42.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $1,000 | $801.25 | 80.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 21 | 22 | $880.00 | $705.10 | 80.1% |
| 92250 | Photography of the retina | Office | 2023 | 12 | 12 | $2,236 | $279.72 | 12.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 15 | $300.00 | $51.15 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 111 | $26,085 | $6,908 | 26.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 46 | 46 | $7,820 | $4,357 | 55.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 43 | 43 | $3,655 | $2,937 | 80.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 51 | 51 | $2,040 | $1,604 | 78.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 23 | 24 | $3,720 | $1,541 | 41.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 26 | $4,030 | $1,394 | 34.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 20 | 20 | $4,700 | $980.13 | 20.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 69 | 81 | $1,620 | $237.18 | 14.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 37 | 37 | $6,290 | $5,223 | 83.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 53 | 77 | $18,045 | $4,800 | 26.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 49 | $7,575 | $2,493 | 32.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 23 | 23 | $3,565 | $1,483 | 41.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 11 | 12 | $480.00 | $217.96 | 45.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 57 | 72 | $1,440 | $216.00 | 15.0% |
About Dr. Candace Nguyen, M.D
Dr. Candace Nguyen, M.D is a Family Medicine healthcare provider based in Woodlyn, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2013. The National Provider Identifier (NPI) number assigned to this provider is 1518300748.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Candace Nguyen, M.D has received a total of $10,363 in payments from pharmaceutical and medical device companies, with $1,755 received in 2024. These payments were reported across 601 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($10,357).
As a Medicare-enrolled provider, Nguyen has provided services to 1,237 Medicare beneficiaries, totaling 1,463 services with total Medicare billing of $71,016. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Woodlyn, PA
- Active Since 04/08/2013
- Last Updated 05/29/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1518300748
Products in Payments
- FARXIGA (Drug) $704.64
- TRELEGY ELLIPTA (Drug) $626.90
- VRAYLAR (Drug) $543.26
- TRULICITY (Drug) $515.81
- Ozempic (Drug) $474.21
- UBRELVY (Drug) $410.76
- MOUNJARO (Drug) $383.96
- MYRBETRIQ (Drug) $366.85
- JARDIANCE (Drug) $351.80
- XIFAXAN (Drug) $305.45
- Vascepa (Drug) $293.30
- JANUVIA (Drug) $278.24
- NURTEC ODT (Drug) $276.88
- Rybelsus (Drug) $254.95
- Saxenda (Drug) $231.22
- REXULTI (Drug) $226.06
- BREZTRI (Drug) $188.37
- Otezla (Drug) $152.03
- ENTRESTO (Drug) $145.12
- TRADJENTA (Drug) $144.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.